The binding of PD-L1 to integrinβ4/integrinβ6 triggers the AKT/GSK3β and STAT3 pathway respectively, resulting in the promotion of glycolysis in cervical and bladder cancer cells97,98. The gene discussed is STAT3; the disease is urinary bladder cancer.